Discovery of High-Affinity Inhibitors of the BPTF Bromodomain.

导出原文传递

翻译打印收藏纠错

作者： Tian,Lu ^[1] ; Haibo,Lu ^[2] ; Zhe,Duan ^[3] ; Jun,Wang ^[4] ; Jie,Han ^[5] ; Senhao,Xiao ^[5] ; HuanHuan,Chen ^[6] ; Hao,Jiang ^[5] ; Yu,Chen ^[5] ; Feng,Yang ^[5] ; Qi,Li ^[7] ; Dongying,Chen ^[5] ; Jin,Lin ^[5] ; Bo,Li ^[5] ; Hualiang,Jiang ^[5] ; Kaixian,Chen ^[7] ; Wenchao,Lu ^[1] ; Hua,Lin ^[5] ; Cheng,Luo ^[5]

作者单位： School of Pharmacy, Fujian Medical University, Fuzhou 350122, China. ^[1] Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, China. ^[2] School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, China. ^[3] School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, China. ^[4] The Chemical Biology Center, Drug Design and Discovery Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China. ^[5] School of Pharmacy, Nanchang University, Nanchang 330006, China. ^[6] Laboratory of Pharmaceutical Analysis, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Zhangjiang Hi-Tech Park, Shanghai, 201203, China. ^[7] Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, California 94305, United States. ^[8] Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou 350117, China. ^[9]